Table 1.
Participant demographics | N = 18 |
---|---|
Age, median (range) | 41 years (18–61 years) |
Female, n (%) | 13 (72%) |
Race, n (%) | |
Caucasian | 17 (94%) |
Other (not specified) | 1 (6%) |
Ethnicity, n (%) | |
Non-Hispanic | 16 (89%) |
Not known | 2 (11%) |
KPS at screening, median (range) | 85 (60–100) |
Genetic severity score | |
1. Tissue mosaic, n (%) | 7 (39%) |
2. Classic, n (%) | 3 (17%) |
3. Severe, n (%) | 8 (44%) |
Target meningioma | N = 18 |
Volume, median (range) | 14.5 cc (3.3–68.2 cc) |
Maximum linear dimension, median (range) | 32.8 mm (20.3–62.9 mm) |
Annualized growth rate at enrollment (%), mean/median | 51%/33% |
Nontarget meningiomas | N = 20 |
Number of participants | 14 |
Volume, median (range) | 2.8 cc (0.9–19.9 cc) |
Annualized growth rate at enrollment (%), mean/median | 38%/14% |
Vestibular schwannomas | N = 21 |
Number of participants | 16 |
Volume, median (range) | 2.70 cc (0.3–4.2 cc) |
Maximum linear measurement (median, range) | 22.9 mm (10–37.2 mm) |
Annualized growth rate at enrollment (%), mean/median | 20%/13% |